Gfinity, Arix Bioscience and Meastrano
Episode 1623, Nov 07, 2019, 01:08 PM
Gfinity discuss their final results and their progress in the world of Esports. Arix Bioscience discuss one of their portfolio company’s new asset. Maestrano talks about the acquisition of Airsight.
On the Vox Markets Podcast Today: 7th November 2019
Graham Wallace Chief Executive Officer of Gfinity #GFIN discusses their final results and their progress in the world of Esports
Jonathan Tobin, Investment Director of Arix Bioscience #ARIX discusses one of their portfolio companies Artios Pharma which has announced the expansion of its DNA Damage Response pipeline with a new asset.
(Interview starts at 29 minutes 23 seconds)
Andrew Pearson, CEO of Maestrano #MNO talks about the acquisition of Airsight an engineering surveying services company that uses AI enabled digital recording devices.
(Interview starts at 27 minutes 51 seconds)
Plus the Top 5 Most Followed Companies & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast